David Silverstein
Partner
Axinn
axxin
Australia
Biography
David Silverstein has over a dozen years of experience handling legal and regulatory matters relating to pharmaceutical and biotech products, having worked on the generic and the brand side. He previously practiced in-house at Par Pharmaceutical and, prior to that, at major New York firms. While in-house, David oversaw and managed all aspects of patent, antitrust, unfair competition and trade secret litigation. He also served as Par’s in-house regulatory counsel, advising on regulatory strategies and frequently representing Par before FDA’s Office of Chief Counsel and other regulators.
Research Interest
Molecular Biology and Molecular Genetics